Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells
Author:
Publisher
Elsevier BV
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference35 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. Clinical significance of morphologic characteristics in triple negative breast cancer;Ryu;J. Korean Surg. Soc.,2011
3. Molecular alterations in triple-negative breast cancer-the road to new treatment strategies;Denkert;Lancet,2017
4. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin. Cancer Res.,2007
5. Targeted therapies for triple-negative breast cancer;Lyons;Curr. Treat. Options Oncol.,2019
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications;Journal of Genetic Engineering and Biotechnology;2024-09
2. Aptamer-mediated therapeutic strategies provide a potential approach for cancer;International Immunopharmacology;2024-07
3. Biomimetic nanodrug blocks CD73 to inhibit adenosine and boosts antitumor immune response synergically with photothermal stimulation;Journal of Nanobiotechnology;2024-04-30
4. Research History, Current Trends, and Future Prospects of Liquid Biopsy in Triple-Negative Breast Cancer: An Analysis from a Global Perspective;2024-04-05
5. Visualization of tumor-associated neutrophils in malignant ascites of ovarian cancer with aptamer-decorated AIE probes;Sensors and Actuators B: Chemical;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3